Human Cell-Derived Microfluidic Devices for 3D Barrier Modeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current experimental systems lack the ability to precisely control mechanical and chemical endothelial microenvironments for investigating human vascular and cellular barrier functions, as they often culture cells on flat, stiff substrates that influence cell-matrix and cell-cell signaling pathways, making it difficult to understand the molecular mechanisms governing barrier function.
Innovation Solution
A microfluidic device is developed with a three-dimensional biomaterial structure enclosed between housing portions, featuring channels configured to model a cellular transport barrier in a flow environment, using fabrication techniques like photolithography and injection molding, and incorporating human-cell-derived extracellular matrix to simulate physiological conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cells are cultured on flat, stiff substrates in standard commercial assays, then the assays are easy to manufacture and operate, but the cell-matrix and cell-cell signaling pathways are influenced, making it difficult to accurately model barrier function
Solution Approach 1:
The patent transitions from two-dimensional flat substrates to three-dimensional microtissue structures embedded in hydrogels. This dimensional change allows cells to experience physiologic ECM architecture and mechanical properties while maintaining controllable microenvironments through the microfluidic device design.
Solution Approach 2:
The patent modifies physical and chemical parameters of the culture substrate by using tunable hydrogels with adjustable stiffness, porosity, and degradation rates. This enables precise control over cell-matrix interactions while maintaining physiological relevance, resolving the contradiction between accuracy and controllability.
2Reliability
If in vivo blood pressures and flows are used, then the physiological accuracy is improved, but the mechanical effects of blood flow cannot be decoupled from changes in nutrient exchange
Solution Approach 1:
The patent separates the coupled physiological parameters by using independent control systems: microfluidic pumps control flow and shear stress independently, while separate reservoirs control nutrient composition and oxygen levels. This segmentation allows physiological accuracy to be maintained while enabling independent modulation of each parameter.
Solution Approach 2:
The patent implements dynamic control capabilities where flow rates, pressures, and nutrient compositions can be adjusted in real-time based on experimental requirements. This dynamic system allows physiological conditions to be replicated while maintaining the ability to decouple and independently control mechanical and chemical parameters.
3Reliability
If three-dimensional biomaterial structures with channels are used to model hollow tissue structures, then the physiological relevance is improved, but the manufacturing precision and alignment requirements increase
Solution Approach 1:
The patent uses sacrificial templates (such as gelatin beads or dissolvable structures) as intermediaries to form channels within the hydrogel. These templates are easily positioned and removed, leaving behind precise channels without requiring complex direct fabrication of channels in the final structure, thus reducing manufacturing precision requirements.
Solution Approach 2:
The patent performs preliminary channel formation by embedding sacrificial templates in the hydrogel before finalizing the device assembly. This preliminary action allows channels to be created in a simplified manner, and the templates are subsequently removed to reveal the final channel structure, reducing the complexity of precise alignment during final device fabrication.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device allows for precise control of blood flow and nutrient exchange, enabling a more accurate modeling of cellular interactions and barrier functions, facilitating high-throughput manufacturing and high-resolution imaging of cellular processes.
Implementation Method 1
positioning a lyophilized hydrogel between the first housing portion and the second housing portion; and supplying water to the lyophilized hydrogel to reconstitute the biomaterial structure
Data Source
AI summary
A method for producing a microfluidic device, the method comprising: producing a first housing portion and a second housing portion; securing the second housing portion to the first housing portion; enclosing a three-dimensional biomaterial structure between the first housing portion and the second housing portion; and forming one or more channel within the biomaterial structure, the one or more channel being configured to model a hollow tissue structure; wherein the biomaterial structure and the one or more channel are configured for modeling a cellular transport barrier in a flow environment.